New enzyme network with competing peptides can make decisions based on external environment

The ability to respond to changing surroundings was once considered exclusive to complex living organisms. Then came ...
Yahoo Finance

Recursion (RXRX) Up on $50M NVDA Investment for AI Drug Discovery

Recursion Pharmaceuticals RXRX announced a significant investment worth $50 million from NVIDIA Corporation NVDA, a renowned technology company specializing in accelerated computing. This investment ...
Nature

Engineering synthetic recursive pathways to generate non-natural small molecules

Recursive pathways are broadly defined as those that catalyze a series of reactions such that the key, bond-forming functional group of the substrate is always regenerated in each cycle, allowing for ...
JSTOR Daily

RECURSIVE INTEGRAL METHOD FOR THE NONLINEAR NON-SELFADJOINT TRANSMISSION EIGENVALUE PROBLEM

The transmission eigenvalue problem is an eigenvalue problem that arises in the scattering of time-harmonic waves by an inhomogeneous medium of compact support. Based on a fourth order formulation, ...
Mena FN

Recursion Announces First Patient Dosed In Phase 2 Clinical Study Of REC-3964, A Potential First-In-Class, Oral, Non-Antibiotic Small Molecule For Recurrent Clostridioides ...

REC-3964 is Recursion's first new chemical entity developed using the RecursionOS. REC-3964 represents a novel, non-antibiotic approach with a unique mechanism of action that binds and blocks ...
Benzinga.com

Recursion Pharmaceuticals Stock Surges On Breakthrough AI Model Launch With MIT

Shares of Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) are trading higher after the company, in collaboration with MIT, announced the release of Boltz-2, a new open-source AI model designed to predict ...